Quantcast
Last updated on April 16, 2014 at 1:21 EDT

Latest Lilly Stories

2013-05-30 12:27:10

INDIANAPOLIS, May 30, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) has issued the following statement from Senior Vice President Bart Peterson regarding today's announcement introducing the Indiana Biosciences Research Institute: "The Indiana Biosciences Research Institute will change the bio-landscape of our region. Indiana's life sciences companies spend billions of dollars in research and development each year to advance health care innovations for improved human health. The...

2013-05-30 08:29:14

INDIANAPOLIS, May 30, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) will present at the Goldman Sachs 34(th) Annual Global Healthcare Conference on Wednesday, June 12th, 2013. David Ricks, Lilly senior vice president and president of Lilly Bio-Medicines, will present from 1:40 p.m. to 2:15 p.m. EDT. A live audio webcast will be available on the Webcasts & Presentations section of Lilly's Investor website at http://investor.lilly.com/events.cfm . Subsequently, a replay of the...

2013-05-20 08:26:46

Video shows how those from the medical field bring patient care experience to pharmaceutical career INDIANAPOLIS, May 20, 2013 /PRNewswire/ -- The many health care providers working at Eli Lilly and Company (NYSE:LLY) - including doctors, nurses, and pharmacists - play a vital role in bringing new and innovative medicines to patients. From research labs to doctors' offices, these Lilly employees bring unique insights about patients, and ensure that patients remain at the center of...

2013-05-14 16:27:23

Data from Pipeline Molecules Targeting Key Cancer Pathways to be Presented INDIANAPOLIS, May 14, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will present data from key molecules that make up its clinical oncology pipeline during the 49(th) Annual Meeting of the American Society of Clinical Oncology (ASCO) held in Chicago, Ill. from May 31 - June 4, 2013. Lilly Oncology's pipeline is one of the most robust in the industry, with more than 20 molecules in early- and...

2013-05-14 08:34:28

INDIANAPOLIS, May 14, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) today announced that John C. Lechleiter, Ph.D., chairman, president, and chief executive officer, underwent scheduled surgery for a dilated aorta on Monday, May 13, 2013. "Dr. Lechleiter's surgeons have advised us that surgery went as expected and the repair to the aorta is functioning as intended," said Kristine A. Courtney, M.D., senior director of Lilly's corporate health services. "Dr. Lechleiter is recovering...

2013-05-10 08:24:53

INDIANAPOLIS, May 10, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today Phase III clinical trial results from enzastaurin's PRELUDE study, which explored the molecule as a monotherapy in the prevention of relapse in patients with diffuse large B-cell lymphoma (DLBCL). The study failed to show a statistically significant increase compared to placebo in disease-free survival in patients at high risk of relapse following rituximab-based chemotherapy. There were no new safety...

2013-05-06 16:28:07

INDIANAPOLIS, May 6, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) today announced that John C. Lechleiter, Ph.D., chairman, president, and chief executive officer, will undergo scheduled surgery for a dilated aorta on Monday, May 13, 2013. This condition was found during unrelated testing and has been asymptomatic. Lechleiter is expected to make a full recovery and return to his duties later this summer. In accordance with the company's bylaws, Derica W. Rice, executive vice...

2013-05-06 16:26:20

INDIANAPOLIS, May 6, 2013 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) today declared a dividend for the second quarter of 2013 of $0.49 per share on outstanding common stock. The dividend is payable June 10, 2013 to shareholders of record at the close of business on May 16, 2013. Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide...

2013-05-02 08:37:45

The SGLT disease education campaign provides resources for healthcare professionals about the role of sodium glucose co-transporters in maintaining blood sugar balance RIDGEFIELD, Conn. and INDIANAPOLIS, May 2, 2013 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company (NYSE: LLY) today announced the launch of an educational campaign designed to provide healthcare professionals (HCPs) with a greater understanding of the role sodium glucose...

2013-04-26 08:23:55

Employees will serve in communities in need, including Johannesburg, South Africa, where they will support Lilly's diabetes partnership with Project HOPE INDIANAPOLIS, April 26, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) celebrated National Volunteer Week April 21-27 by sending off the first of 200 volunteers who will serve in impoverished communities throughout 2013. They are part of Connecting Hearts Abroad, Lilly's global employee volunteer program launched in 2011....